152 related articles for article (PubMed ID: 8483882)
1. H-ras-1 point mutations in soft tissue sarcomas.
Wilke W; Maillet M; Robinson R
Mod Pathol; 1993 Mar; 6(2):129-32. PubMed ID: 8483882
[TBL] [Abstract][Full Text] [Related]
2. H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes.
Yoo J; Robinson RA; Lee JY
Mod Pathol; 1999 Aug; 12(8):775-80. PubMed ID: 10463479
[TBL] [Abstract][Full Text] [Related]
3. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients.
Yoo J; Robinson RA
Cancer; 1999 Jul; 86(1):58-63. PubMed ID: 10391564
[TBL] [Abstract][Full Text] [Related]
4. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.
Bohle RM; Brettreich S; Repp R; Borkhardt A; Kosmehl H; Altmannsberger HM
Am J Pathol; 1996 Mar; 148(3):731-8. PubMed ID: 8774129
[TBL] [Abstract][Full Text] [Related]
5. H-ras-1 gene mutations in basal cell carcinoma: automated direct sequencing of clinical specimens.
Wilke WW; Robinson RA; Kennard CD
Mod Pathol; 1993 Jan; 6(1):15-9. PubMed ID: 8426854
[TBL] [Abstract][Full Text] [Related]
6. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
[TBL] [Abstract][Full Text] [Related]
7. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
Stratton MR; Fisher C; Gusterson BA; Cooper CS
Cancer Res; 1989 Nov; 49(22):6324-7. PubMed ID: 2680062
[TBL] [Abstract][Full Text] [Related]
8. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
[TBL] [Abstract][Full Text] [Related]
9. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
11. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
12. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
[TBL] [Abstract][Full Text] [Related]
13. ras gene mutations in human prostate cancer.
Carter BS; Epstein JI; Isaacs WB
Cancer Res; 1990 Nov; 50(21):6830-2. PubMed ID: 2208148
[TBL] [Abstract][Full Text] [Related]
14. [Low incidence of point mutation of N-ras oncogene in human gliomas].
Tsurushima H; Ohno T; Tsuboi K; Yoshii Y; Meguro K; Nose T
No Shinkei Geka; 1995 Jul; 23(7):581-6. PubMed ID: 7637839
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
16. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
[TBL] [Abstract][Full Text] [Related]
17. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
18. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of RAS point mutations in papillary thyroid carcinoma; a novel mutation at codon 31 of K-RAS.
Cyniak-Magierska A; Brzeziańska E; Januszkiewicz-Caulier J; Jarzab B; Lewiński A
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):594-9. PubMed ID: 17943694
[TBL] [Abstract][Full Text] [Related]
20. Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients.
Jin Y; Shima Y; Furu M; Aoyama T; Nakamata T; Nakayama T; Nakamura T; Toguchida J
Anticancer Res; 2010 Jan; 30(1):245-51. PubMed ID: 20150643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]